» Articles » PMID: 18442868

Disease Management Programmes for Patients with Coronary Heart Disease--an Empirical Study of German Programmes

Overview
Journal Health Policy
Date 2008 Apr 30
PMID 18442868
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate healthcare and outcomes of disease management programmes (DMPs) for patients with coronary heart disease (CHD) in primary care, and to assess selection of enrollment for these programmes.

Methods: A cross-sectional survey of 2330 statutorily insured patients with a history of acute myocardial infarction (AMI) was performed in 2006 by the population-based KORA Myocardial Infarction Register from the region of Augsburg, Germany. Patients enrolled in DMP-CHDs receive evidence-based care, with patients not enrolled receiving standard care. To control for selection bias, a propensity score approach was used.

Results: Main factors influencing DMP participation were age (OR 0.98, 95% CI 0.96-0.99), diabetes (OR 1.56, CI 1.25-1.95) and time since last heart attack (OR 0.98, CI 0.95-0.99). Significantly more patients enrolled in DMP-CHDs stated that they received medical counselling for smoking (OR 3.77, CI 1.07-13.34), nutrition (OR 2.15, 1.69-2.74) and for physical activity (OR 2.58, 1.99-3.35). Furthermore, prescription of statins (OR 1.58, CI 1.24-2.00), antiplatelets (OR 1.96, CI 1.43-2.69) and beta-blockers (not significant) were higher in the DMP group. With respect to outcomes, we did not see relevant differences in quality of life and body mass index, and only a minor reduction in smoking.

Conclusions: Enrollment into DMPs for CHD exhibits systematic selection effects. Participants tend to experience--at least on a short to medium term and for AMI patients--better quality of healthcare services. However, since DMP-CHDs were initiated only 2 years ago, we were unable to identify significant improvements in health outcomes. Only the reduction in smoking provides a first indication of better quality outcomes following DMP-CHD. Thus, policy-makers must provide appropriate incentives to sickness funds and physicians in order to ensure initiation and continuation of high quality DMPs.

Citing Articles

Chronic disease management in patients with intellectual disabilities: a matched study in Dutch general practice.

van den Bemd M, Cuypers M, Schalk B, Leusink G, Bischoff E Br J Gen Pract. 2023; 73(735):e744-e751.

PMID: 37666513 PMC: 10498381. DOI: 10.3399/BJGP.2023.0029.


The Impact of the COVID-19 Pandemic on Avoidance of Health Care, Symptom Severity, and Mental Well-Being in Patients With Coronary Artery Disease.

Maehl N, Bleckwenn M, Riedel-Heller S, Mehlhorn S, Lippmann S, Deutsch T Front Med (Lausanne). 2022; 8:760265.

PMID: 34977066 PMC: 8714893. DOI: 10.3389/fmed.2021.760265.


Effectiveness of the German disease management programs: quasi-experimental analyses assessing the population-level health impact.

Burns J, Kurz C, Laxy M BMC Public Health. 2021; 21(1):2092.

PMID: 34781907 PMC: 8591814. DOI: 10.1186/s12889-021-12050-7.


Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data.

Fischer C, Hopner J, Hartwig S, Noutsias M, Mikolajczyk R BMC Cardiovasc Disord. 2021; 21(1):18.

PMID: 33407174 PMC: 7788767. DOI: 10.1186/s12872-020-01832-3.


Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.

Kirsch F, Becker C, Schramm A, Maier W, Leidl R Eur J Health Econ. 2020; 21(4):607-619.

PMID: 32006188 PMC: 7214389. DOI: 10.1007/s10198-020-01158-z.